Arid5a cooperates with Sox9 to stimulate chondrocyte-specific transcription

Molecular Biology of the Cell

Volumn 22, Issue 8, 2011, Pages 1300-1311

  Amano, Katsuhiko ^a   Hata, Kenji ^a   Muramatsu, Shuji ^b   Wakabayashi, Makoto ^a,b   Takigawa, Yoko ^a   Ono, Koichiro ^a   Nakanishi, Masako ^a   Takashima, Rikako ^a   Kogo, Mikihiko ^a   Matsuda, Akio ^b   Nishimura, Riko ^a   Yoneda, Toshiyuki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Departments of Asahikasei Pharma   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AT RICH INTERACTIVE DOMAIN CONTAINING PROTEIN 5A; COMPLEMENTARY DNA; HISTONE H3; NUCLEAR PROTEIN; PROTEIN COL2A1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CARTILAGE CELL; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DNA LIBRARY; HISTONE ACETYLATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; UPREGULATION;

ADENOVIRIDAE; ANIMALS; CARRIER PROTEINS; CARTILAGE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHONDROCYTES; CHONDROGENESIS; COLLAGEN TYPE II; EMBRYO, MAMMALIAN; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; GENE LIBRARY; LUCIFERASES, FIREFLY; MICE; ORGAN CULTURE TECHNIQUES; PLASMIDS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; SOX9 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION;

EID: 79954614546     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-07-0566     Document Type: Article

References (49)

1. Akiyama H (2008). Control of chondrogenesis by the transcription factor Sox9. Mod Rheumatol 18, 213-219.
2. Akiyama H, Chaboissier MC, Behringer RR, Rowitch DH, Schedl A, Epstein JA, de Crombrugghe B (2004). Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc Natl Acad Sci USA 101, 6502-6507. (Pubitemid 38586003)
3. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B (2002). The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16, 2813-2828. (Pubitemid 35253149)
4. Amano K, Hata K, Sugita A, Takigawa Y, Ono K, Wakabayashi M, Kogo M, Nishimura R, Yoneda T (2009). Sox9 family members negatively regulate maturation and calcification of chondrocytes through up-regulation of parathyroid hormone-related protein. Mol Biol Cell 20, 4541-4551.
5. Amano K, Ichida F, Sugita A, Hata K, Wada M, Takigawa Y, Nakanishi M, Kogo M, Nishimura R, Yoneda T (2008). MSX2 stimulates chondrocyte maturation by controlling Ihh expression. J Biol Chem 283, 29513-29521.
6. Barrionuevo F, Taketo MM, Scherer G, Kispert A (2006). Sox9 is required for notochord maintenance in mice. Dev Biol 295, 128-140. (Pubitemid 44063495)
7. Bell DM, Leung KK, Wheatley SC, Ng LJ, Zhou S, Ling KW, Sham MH, Koopman P, Tam PP, Cheah KS (1997). SOX9 directly regulates the type-II collagen gene. Nat Genet 16, 174-178. (Pubitemid 27240616)
8. Bridgewater LC, Lefebvre V, de Crombrugghe B (1998). Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J Biol Chem 273, 14998-15006. (Pubitemid 28272793)
9. Cook PR (1999). The organization of replication and transcription. Science 284, 1790-1795.
10. de Crombrugghe B, Lefebvre V, Behringer RR, Bi W, Murakami S, Huang W (2000). Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol 19, 389-394.
11. Foster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller PA, Stevanovic M, Weissenbach J, Mansour S, Young ID, Goodfellow PN (1994). Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372, 525-530. (Pubitemid 24368528)
12. Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H (2005a). Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J Biol Chem 280, 8343-8350. (Pubitemid 40349737)
13. Furumatsu T, Tsuda M, Yoshida K, Taniguchi N, Ito T, Hashimoto M, Ito T, Asahara H (2005b). Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J Biol Chem 280, 35203-35208. (Pubitemid 41532707)
14. Gartland A, Mechler J, Mason-Savas A, MacKay CA, Mailhot G, Marks Jr SC, Odgren PR (2005). In vitro chondrocyte differentiation using costochondral chondrocytes as a source of primary rat chondrocyte cultures: An improved isolation and cryopreservation method. Bone 37, 530-544. (Pubitemid 41317326)
15. Georgescu SP, Li JH, Lu Q, Karas RH, Brown M, Mendelsohn ME (2005). Modulator recognition factor 1, an AT-rich interaction domain family member, is a novel corepressor for estrogen receptor alpha. Mol Endocrinol 19, 2491-2501. (Pubitemid 41362663)
16. Gordon CT, Tan TY, Benko S, Fitzpatrick D, Lyonnet S, Farlie PG (2009). Long-range regulation at the SOX9 locus in development and disease. J Med Genet 46, 649-656.
17. Han Y, Lefebvre V (2008). L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol Cell Biol 28, 4999-5013.
18. Hanover JA, Love DC, Prinz WA (2009). Calmodulin-driven nuclear entry: Trigger for sex determination and terminal differentiation. J Biol Chem 284, 12593-12597.
19. Hata K, Nishimura R, Muramatsu S, Matsuda A, Matsubara T, Amano K, Ikeda F, Harley VR, Yoneda T (2008). Paraspeckle protein p54nrb links Sox9-mediated transcription with RNA processing during chondrogenesis in mice. J Clin Invest 118, 3098-3108.
20. Hattori T, Coustry F, Stephens S, Eberspaecher H, Takigawa M, Yasuda H, de Crombrugghe B (2008). Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5. Nucleic Acids Res 36, 3011-3024. (Pubitemid 351737193)
21. Hattori T et al. (2010). SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. Development 137, 901-911.
22. Horiuchi K et al. (2009). Conditional inactivation of TACE by a Sox9 promoter leads to osteoporosis and increased granulopoiesis via dysregulation of IL-17 and G-CSF. J Immunol 182, 2093-2101.
23. Huang W, Chung UI, Kronenberg HM, de Crombrugghe B (2001). The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci USA 98, 160-165. (Pubitemid 32095880)
24. Kamiya N, Jikko A, Kimata K, Damsky C, Shimizu K, Watanabe H (2002). Establishment of a novel chondrocytic cell line N1511 derived from p53-null mice. J Bone Miner Res 17, 1832-1842.
25. Kawakami Y, Tsuda M, Takahashi S, Taniguchi N, Esteban CR, Zemmyo M, Furumatsu T, Lotz M, Belmonte JC, Asahara H (2005). Transcriptional coactivator PGC-1alpha regulates chondrogenesis via association with Sox9. Proc Natl Acad Sci USA 102, 2414-2419. (Pubitemid 40279390)
26. Kronenberg HM (2003). Developmental regulation of the growth plate. Nature 423, 332-336. (Pubitemid 40852707)
27. Kronenberg HM (2006). PTHrP and skeletal development. Ann NY Acad Sci 1068, 1-13. (Pubitemid 43824131)
28. Lahoud MH et al. (2001). Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Genome Res 11, 1327-1334. (Pubitemid 32771539)
29. Lefebvre V, Li P, de Crombrugghe B (1998). A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17, 5718-5733. (Pubitemid 28445983)
30. Lefebvre V, Zhou G, Mukhopadhyay K, Smith CN, Zhang Z, Eberspaecher H, Zhou X, Sinha S, Maity SN, de Crombrugghe B (1996). An 18-base-pair sequence in the mouse proalpha1(II) collagen gene is sufficient for expression in cartilage and binds nuclear proteins that are selectively expressed in chondrocytes. Mol Cell Biol 16, 4512-4523. (Pubitemid 26251253)
31. Muramatsu S et al. (2007). Functional gene screening system identified TRPV4 as a regulator of chondrogenic differentiation. J Biol Chem 282, 32158-32167. (Pubitemid 350106454)
32. Nel-Themaat L, Vadakkan TJ, Wang Y, Dickinson ME, Akiyama H, Behringer RR (2009). Morphometric analysis of testis cord formation in Sox9-EGFP mice. Dev Dyn 238, 1100-1110.
33. Nifuji A, Kellermann O, Noda M (2004). Noggin inhibits chondrogenic but not osteogenic differentiation in mesodermal stem cell line C1 and skeletal cells. Endocrinology 145, 3434-3442. (Pubitemid 38830016)
34. Nishimura R, Hata K, Ikeda F, Ichida F, Shimoyama A, Matsubara T, Wada M, Amano K, Yoneda T (2008). Signal transduction and transcriptional regulation during mesenchymal cell differentiation. J Bone Miner Metab 26, 203-212. (Pubitemid 351677844)
35. Ornitz DM, Marie PJ (2002). FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16, 1446-1465.. (Pubitemid 34686327)
36. Saito T, Ikeda T, Nakamura K, Chung UI, Kawaguchi H (2007). S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes. EMBO Rep 8, 504-509. (Pubitemid 46696522)
37. Schmahl J, Raymond CS, Soriano P (2007). PDGF signaling specificity is mediated through multiple immediate early genes. Nat Genet 39, 52-60. (Pubitemid 46026501)
38. Shimoyama A et al. (2007). Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell 18, 2411-2418. (Pubitemid 47025707)
39. Smits P, Dy P, Mitra S, Lefebvre V (2004). Sox5 and Sox6 are needed to develop and maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate. J Cell Biol 164, 747-758. (Pubitemid 38282958)
40. Smits P, Li P, Mandel J, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B, Lefebvre V (2001). The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 1, 277-290. (Pubitemid 33653062)
41. Sock E, Pagon RA, Keymolen K, Lissens W, Wegner M, Scherer G (2003). Loss of DNA-dependent dimerization of the transcription factor SOX9 as a cause for campomelic dysplasia. Hum Mol Genet 12, 1439-1447. (Pubitemid 36758456)
42. Thomsen MK, Francis JC, Swain A (2008). The role of Sox9 in prostate development. Differentiation 76, 728-735. (Pubitemid 352032748)
43. Thrower AR, Bullock GC, Bissell JE, Stinski MF (1996). Regulation of a human cytomegalovirus immediate-early gene (US3) by a silencer-enhancer combination. J Virol 70, 91-100. (Pubitemid 126508773)
44. Valentine SA, Chen G, Shandala T, Fernandez J, Mische S, Saint R, Courey AJ (1998). Dorsal-mediated repression requires the formation of a multiprotein repression complex at the ventral silencer. Mol Cell Biol 18, 6584-6594. (Pubitemid 28500547)
45. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelli FD, Keutel J, Hustert E (1994). Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79, 1111-1120.
46. Whitson RH, Tsark W, Huang TH, Itakura K (2003). Neonatal mortality and leanness in mice lacking the ARID transcription factor Mrf-2. Biochem Biophys Res Commun 312, 997-1004. (Pubitemid 37490914)
47. Wilsker D, Patsialou A, Dallas PB, Moran E (2002). ARID proteins: A diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development. Cell Growth Differ 13, 95-106. (Pubitemid 34507099)
48. Xu M, Cook PR (2008). Similar active genes cluster in specialized transcription factories. J Cell Biol 181, 615-623. (Pubitemid 351717509)
49. Yasoda A, Ogawa Y, Suda M, Tamura N, Mori K, Sakuma Y, Chusho H, Shiota K, Tanaka K, Nakao K (1998). Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway. J Biol Chem 273, 11695-11700. (Pubitemid 28272071)